English
Polski
Español
українська
Anticoagulation as VTE prophylaxis in hospitalized patients
How long should anticoagulant treatment be used as venous thromboembolism (VTE) prophylaxis in hospitalized patients? Should it be continued after discharge?
2020-07-27
How long should anticoagulant treatment be used as venous thromboembolism (VTE) prophylaxis in hospitalized patients? Should it be continued after discharge?
What is the current role of mechanical venous thromboembolism (VTE) prophylaxis?
Who should receive venous thromboembolism (VTE) prophylaxis before a long-haul flight? What form of prophylaxis should be used?
What should be the diagnostic workup in a patient with suspected deep vein thrombosis (DVT)?
What deep vein thrombosis (DVT) prophylaxis should be used in an older bedridden patient in a long-term care facility? What do you think about heparin or compression stockings in such settings?
Is there still a place for unfractionated heparin and low-molecular-weight heparin (LMWH) in the current management of venous thromboembolism (VTE)? When to use them?
What is the best approach to antiplatelet treatment in patients on long-term anticoagulation?
What antithrombotic prophylaxis should be used in acutely ill hospitalized medical patients? Should it be used in such patients who remain at home or in long-term care institutions?
The diagnosis of venous thromboembolism (VTE) is based on assessment of the population pretest probability (PTP) of VTE. How to assess this probability?
What scoring systems are used in patients with pulmonary embolism?
